Large Clinical Trials Webinar

External Event - 13th May 2020


We are delighted to present you with five of the highest-rated research works which are part of our scientific programme


  • Welcome and opening remarks from the ESO and WSO Presidents and the Webinar Chairs (3min)
  • Trial 1: Efficacy of Fluoxetine: A Randomized Controlled Trial in Stroke (Effects) Assoc. Prof. Erik Lundström (Sweden) Department of Neuroscience, Neurology, Uppsala University, Akademiska Sjukhuset, Uppsala, Sweden
  • Trial 2: Assessment of Fluoxetine in Stroke Recovery (Affinity): Results of a Double-blind, Placebo-controlled, Randomised Trial Prof. Graeme Hankey (Australia) Department of Neurology, Medical School, Faculty of Health and Medical Sciences, The University of Western Australia
  • Trial 3: A Randomized Trial of Direct Endovascular Thrombectomy Versus Thrombectomy Preceded by Intravenous Alteplase in Acute Ischemic Stroke Prof. Jianmin Liu (China) Changhai Hospital in Shanghai, Department of Neurosurgery, Cerebrovascular Center, China
  • Trial 4: The Basilar Artery International Collaboration Study (Basics): A Randomized Controlled Trial of Endovascular Therapy in Basilar Artery Occlusion Dr. Wouter Schonewille (Netherlands) Department of Neurology, St. Antonius Hospital, Nieuwegein, The Netherlands
  • Trial 5: Ascot Trial: The Effect of Randomisation to Atorvastatin or Placebo, and Amlodipine-based or Beta-blocker-based Regime on 20-year Incidence of Stroke or Dementia Dr. William Whiteley (UK) Senior Lecturer, CCBS, University of Edinburgh, Honorary Consultant Neurologist, NHS Lothian, Senior Clinical Fellow, NDPH, University of Oxford
  • Closing remarks


  • When: Wed, May 13, 2020 at 12:00 PM London (GMT 1:00) 
  • Duration: 2 hours
  • Price: Free
  • Language: English
  • Who can attend? Anyone with the event link can attend
  • Dial-in available? (listen only): Not available.

< Back to Events